Life Sciences & MedTech

Building a new class of cell-based therapies for advanced solid cancers.

Ailurus is a biocomputer company that establishes architecture and language to program biology. Our mission is to make biology a general-purpose technology that is easy to use as computers.

Autolus is a clinical-stage biopharmaceutical company developing next-generation, programmed T cell therapies for the treatment of cancer.

Avacta is shaping the future of medicine with powerful therapeutic and diagnostic platforms. They are a clinical stage oncology drug company and developer of powerful diagnostics.

Developing a platform technology that selects potent immune cells pre-clinically to streamline, accelerate and de-risk the development of the next generation of cellular immunotherapies.

Developing a novel approach to gene synthesis that will speed up and lower the cost of biological research.

CC Bio harness the power of synthetic biology to engineer and edit the microbiome with surgical precision. Their goal is to eliminate microbiome-based disease in a potent, specific and prophylactic fashion, harmonising the relationship between eukaryotic and microbial cells.

Clinical Trials Laboratory Services (CTLS) is a leading provider of human blood products and biological specimens to the research community. CTLS specialises in the collection of whole blood, serum, white cells, red cells and other biofluids from consented donors.

Complement Therapeutics is an early-stage biotechnology company focused on the research and development of novel therapeutics for complement-mediated diseases.

Developed a proprietary nanoparticle technology that ensures precise RNA delivery to a wide range of previously inaccessible tissues.

Developing a platform utilising artificial intelligence (AI) targeting monogenic (single gene) and common diseases.

Developing new and innovative disruptive technologies for patients with common & rare diseases, essentially developing “life-long” and “lower cost” Gene Therapies.

DNAe is pioneering semiconductor sequency technology to bring patients the benefits of fast and insightful diagnostics.

Endress+Hauser is a global leader in measurement and automation technology for process and laboratory applications.

Engitix mission is to develop novel and better therapies to treat advance fibrosis and solid tumours, with an initial focus on gastrointestinal diseases.

Esox Biologics is a biotechnology company providing molecular diagnostics and targeted therapeutics to aquatic veterinarians.

A precision biomarker company providing groundbreaking molecular insights to facilitate drug discovery, diagnostics, and personalized medicine

George Medicines’ mission is to extend and improve the lives of millions of people suffering from the world’s leading causes of death and disability, such as hypertension, cardiovascular disease and type 2 diabetes.

Impli is a biotech company making people’s lives safer and healthier using implantable technology.

Kodiform Therapeutics aims to develop small molecule inhibitors targeting intrinsically disordered proteins using intracellular antibody based screening technology.

Intrinsically disordered proteins were considered to be undruggable as they lack a defined three-dimensional structure and available binding pockets. By utilising our diverse intracellular antibody libraries, Kodiform Therapeutics will identify new binding sites on these disordered proteins, use these antibodies to determine biophysical characteristics of these proteins, with the aim of developing small molecule drugs to inhibit their protein-protein interactions.

The London Biofoundry is a core facility of SynbiCITE, located at the Innovation and Translation Hub on the White City campus of Imperial College, which specialises in the design, engineering and functional characterisation of synthetic DNA and organisms for academic and industrial clients

MediSieve are developing Magnetic Blood Filtration, a first of its kind drug-device combination platform that enables the removal of specific substances from the bloodstream.

A clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases.

Micrographia Bio is on a mission to resolve the true molecular functions of potential therapeutics to transform drug discovery.

MiNA Therapeutics’ platform enables the development of new medicines that restore normal function to patients’ cells. They are applying their technology and clinical know-how to transform the therapy landscape in cancer and other diseases.

Mitra Bio has the mission to use genomics to increase health span and enable precision therapies for the skin.

Mytos are helping researchers to accelerate the speed and quality of their research with automated cell culture.

Novartis is a global leader in healthcare using science-based innovation to deliver better patient outcomes.

P.Happi is a biotech company developing microbiome-based female health products.

Non-invasive cervical screening. Tests for cancer-causing HPV strains in your menstrual blood at the standards required by the NHS and WHO.

Pear Bio help doctors and pharma companies evaluate cancer drug efficacy using organ-on-a-chip and computer vision.

PentaBind is a VC-backed platform TechBio company using Generative Artificial Intelligence, Oligos (Aptamers) and Multiomics to design safer and better drug candidates for oncology.

Developing the next-generation proteomics tools that will enable a new wave of better and faster drug discovery.

Quell are seeking to delivery truly innovative, life changing therapies for their patients. Their vision is to build a major global biopharmaceutical company bringing transformational and valued therapies for a range of autoimmune and inflammatory diseases.

Resolution Therapeutics is a biotechnology company developing macrophage cell therapy to treat inflammatory organ disease.

Resurrect Bio is a plant biotech start-up, working on how to improve the immune system of crop species.

RQ Biotechnology’s mission is to develop medicines based on potent broad-spectrum monoclonal antibodies to provide instant and long-lasting protection for vulnerable people.

Second Nature have brought together nutritional, clinical and behavioural science to develop a programme that gradually introduces new habits that fit in with your lifestyle.

Sequential Skin is revolutionising skin health with the world’s first consumer skin microbiome test.

Works with academia, investors, pharma and biotech by performing research that leverages genetic data to help inform drug discovery and development.

Building the next-generation of high efficacy, low side-effect cancer therapeutics.

Sixfold is tackling the biggest challenge in RNA therapeutics: how to safely deliver RNA to diseased cells. They’re an inclusive, diverse and highly motivate team of engineers, builders, scientists and operators redefining the future of RNA.

Developing technologies to help patients, clinicians, and healthcare systems better manage chronic respiratory conditions through smart sensors, mobile apps, and cloud platforms that improve adherence, reduce hospital admissions, and support remote monitoring and diagnosis.

SPARTA Biodiscovery is a company developing and commercialising the SPARTA® technology. SPARTA® (Single Particle Automated Raman Trapping Analysis) is a breakthrough analytical technology for automated, label-free comprehensive characterisation of nanoformulations.

Developing a multi-cancer early detection breath test for improved cancer survival.

Synteny builds the AI platform to power disease discoveries from immune data

Synthace is a software company enabling life sciene, the way it should be done. They’re delivering a life sciences R&D cloud to scientists who want to innovate faster.

An independent global medical research institute with a mission to improve the lives of millions of people worldwide.

DigiFab is leading a new era of digital molecular design and fabrication for a smart, healthy and sustainable society.

Valink Therapeutics is focused on the development of next generation antibody-based therapeutics.

Mission is to provide end-to-end solutions for all gene delivery needs spanning both research and therapy.

Vita Healthcare Innovation want to empower health systems and innovators to realise their true potential so they can improve the lives of individuals and populations.

Woost is aiming to track biomarkers in menstrual blood to help women with the diagnosis of gynaecological conditions.